Media Thread, page-14970

After listening for a second time, the message in the last few minutes was very clear.

It drills down on LC’s earlier comments about US investors very interested in ONCARLYTICS because there is nothing else out there like it. It’s uniquex

PH was very clear and adamant he is plugged in to the US Biotech Ecosystem and knows exactly what they want. They want the DATA. LC came in over the top of PH yo emphasise that point.

LC has now told us several times she expects early data from ONCARLYTICS before Xmas. It’s now 5 months since the first Monotherapy Bilary Cancer patient was dosed with Mono-Oncarlytics.

It sure looks like IMU will be off to the Nasdaq soon after the data is released. With a big capital injection from US Funds. I’d say it will be a full listing.

The question that’s most important is how high the SP will go on positive news from Oncarlytics, Bile Duct Vaxinia and Azercel-Cel data.

Because the higher we run the less dilution.
But if this is going to run the Nasdaq is the place to drop it.